CAR-T therapy has been effective in treating relapsed/refractory hematologic cancers like multiple myeloma and diffuse large B-cell lymphoma, especially in older adults.
Tailoring CAR-T Therapy for Older Adults: Addressing Frailty and Improving Outcomes
Kate Bondaruk2024-10-11T18:46:14+00:00October 11th, 2024|multiple myeloma|Comments Off on Tailoring CAR-T Therapy for Older Adults: Addressing Frailty and Improving Outcomes